Skip to main content
    D

    DR Horton Inc (DHI)

    Official site

    CONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE

    $144.79
    -0.76 (-0.52%)

    Market Cap: $39.51B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    DR Horton Inc (DHI) Financials: Revenue, Profit and Cash Flow

    Updated Jul 21, 2026. Financial statements from company filings, amounts in US dollars.

    DR Horton reported revenue of $34.25B for the fiscal year ended Sep 30, 2025, down 6.9% from the year before. That year, net income was $3.62B with a net margin of 10.6%, operating cash flow was $3.42B and free cash flow was $3.28B. The quarter ended Jun 30, 2026 had revenue of $9.23B and net income of $918.70M.

    Revenue and Margins

    The operating margin was 12.9% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $12.16B, a compound annual rate of 12.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$34.25B-6.9%23.7%12.9%10.6%
    Sep 2024$36.80B+3.8%25.9%16.1%13.1%
    Sep 2023$35.46B+5.9%26.4%17.2%13.5%
    Sep 2022$33.48B+20.5%31.4%22.6%17.6%
    Sep 2021$27.77B+36.7%28.4%19.2%15.1%
    Sep 2020$20.31B+15.5%24.3%14.5%11.7%
    Sep 2019$17.59B+9.5%22.0%11.9%9.2%
    Sep 2018$16.07B+14.0%22.8%12.5%9.1%
    Sep 2017$14.09B+15.9%21.6%11.2%7.4%
    Sep 2016$12.16BN/A21.8%11.0%7.3%
    Annual, fiscal years ended Sep 2016 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, net income fell 24.7% from the year before. In the quarter ended Jun 2026, net income fell 10.8% from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Revenue$34.25B$36.80B$35.46B$33.48B$27.77B$20.31B$17.59B$16.07B$14.09B$12.16B
    Cost of revenue$26.13B$27.27B$26.11B$22.98B$19.90B$15.37B$13.72B$12.40B$11.04B$9.50B
    Gross profit$8.12B$9.54B$9.35B$10.50B$7.88B$4.94B$3.87B$3.67B$3.05B$2.65B
    Operating income$4.42B$5.94B$6.10B$7.57B$5.33B$2.95B$2.09B$2.01B$1.58B$1.33B
    Net income$3.62B$4.81B$4.80B$5.90B$4.19B$2.38B$1.62B$1.46B$1.04B$886.30M
    EBITDA$4.84B$6.37B$6.41B$7.71B$5.46B$3.07B$2.21B$2.13B$1.66B$1.42B
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$9.23B$7.56B$6.89B$9.68B$9.23B$7.73B$7.61B$10.00B$9.97B$9.11B$7.73B$10.50B
    Gross profit$2.15B$1.70B$1.59B$2.10B$2.21B$1.90B$1.91B$2.55B$2.64B$2.33B$2.01B$2.82B
    Operating income$1.16B$800.00M$729.60M$1.13B$1.26B$1.00B$1.03B$1.59B$1.72B$1.45B$1.17B$1.94B
    Net income$918.70M$658.00M$601.40M$916.80M$1.03B$819.10M$851.90M$1.30B$1.37B$1.18B$955.70M$1.53B
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, total debt of $11.93B exceeded cash and equivalents by $8.95B.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Total assets$35.47B$36.10B$32.58B$30.35B$24.02B$18.91B$15.61B$14.11B$12.18B$11.56B
    Current assets$28.32B$29.45B$26.27B$24.23B$19.72B$3.04B$12.80B$11.90B$10.26B$9.65B
    Cash and equivalents$2.99B$4.52B$3.87B$2.54B$3.21B$3.02B$1.49B$1.47B$1.01B$1.30B
    Total liabilities$10.73B$10.28B$9.44B$10.57B$8.80B$6.79B$5.31B$4.96B$4.44B$4.77B
    Short-term debt$5.97B$563.00M$5.09B$6.07B$5.41B$4.28B$3.40B$3.20B$2.45B$2.80B
    Long-term debt$5.97B$5.92B$5.09B$6.07B$5.41B$4.28B$2.51B$3.20B$2.87B$3.27B
    Shareholder equity$24.19B$25.31B$22.70B$19.40B$14.89B$11.84B$10.02B$8.98B$7.75B$6.79B
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$36.51B$35.57B$34.64B$35.47B$36.40B$35.69B$35.03B$36.10B$35.15B$34.40B$33.38B$32.58B
    Total liabilities$12.10B$11.37B$10.08B$10.73B$11.80B$10.83B$9.57B$10.28B$10.00B$10.10B$9.78B$9.44B
    Cash and equivalents$2.08B$1.92B$2.51B$2.99B$2.61B$2.47B$3.05B$4.52B$2.99B$3.06B$3.32B$3.87B
    Shareholder equity$23.82B$23.63B$24.00B$24.19B$24.05B$24.33B$24.94B$25.31B$24.66B$23.82B$23.15B$22.70B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Sep 2025, free cash flow was 95.9% of operating cash flow. Dividends and share repurchases together came to 145.7% of it.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Operating cash flow$3.42B$2.19B$4.30B$561.80M$534.40M$1.42B$892.10M$545.20M$440.20M$623.90M
    Capital expenditures$137.40M$165.30M$148.60M$148.20M$267.40M$286.80M$224.10M$138.30M$157.30M$86.10M
    Free cash flow$3.28B$2.02B$4.16B$413.60M$267.00M$1.13B$668.00M$406.90M$282.90M$537.80M
    Dividends paid$494.80M$395.20M$341.20M$316.50M$289.30M$256.00M$227.30M$191.60M$149.60M$118.70M
    Share repurchases$4.28B$1.79B$1.18B$1.13B$848.40M$360.40M$479.80M$127.50M$60.60M$0
    Investing cash flow-$168.70M-$190.60M-$310.20M-$414.90M-$252.20M-$166.10M-$394.00M$19.00M-$164.00M-$112.60M
    Financing cash flow-$4.76B-$1.36B-$2.67B-$811.20M-$85.10M$270.60M-$490.10M-$82.50M-$564.60M-$591.90M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$439.30M-$412.50M$854.00M$2.47B$738.60M-$436.20M$646.70M$1.96B$698.30M-$316.70M-$153.40M$2.04B
    Capital expenditures$42.00M$37.20M$27.40M$43.80M$46.00M$34.30M$13.30M$32.00M$62.00M$23.70M$47.60M$40.30M
    Free cash flow$397.30M-$449.70M$826.60M$2.43B$692.60M-$470.50M$633.40M$1.93B$636.30M-$340.40M-$201.00M$2.00B
    Last 12 quarters

    Frequently Asked Questions About DHI

    What is DR Horton's annual revenue?

    DR Horton reported revenue of $34.25B for the fiscal year ended Sep 30, 2025.

    How fast is DR Horton's revenue growing?

    Revenue was down 6.9% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.8%.

    Is DR Horton profitable?

    Yes. DR Horton reported net income of $3.62B for the fiscal year ended Sep 30, 2025, with a net margin of 10.6%.

    How much free cash flow does DHI generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of $3.42B minus capital expenditures of $137.40M produced free cash flow of $3.28B.

    How much debt does DR Horton have?

    The balance sheet dated Sep 30, 2025 reported long-term debt of $5.97B, short-term debt of $5.97B and cash and equivalents of $2.99B.